Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-Bupivacaine vs Bupivacaine + IV Ketamine in Brachial Plexus Block
NCT05315271Phase 1Completed
- Sponsor
- Sohag University
- Start
- Jun 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of ketamine in pain (2 arms), sponsored by Sohag University. Primary endpoint: Comparison of the efficacy of adding ketamine to bupivacaine versus intravenous ketamine infusion with supraclavicular brachial plexus block in upper limb surgeries of sensory block at 24 hours. Started Jun 2022; status: completed.
02
Drugs
ketamine
03
Conditions
pain
Beyond the preview
Go deeper on NCT05315271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05315271.